APPlexus Hot Topics 2024

Stream on-demand webcasts and follow along with downloadable slides from APPlexus Hot Topics 2024, designed and tailored specifically for advanced practice providers, to learn about the latest updates in management of biliary tract cancer, bladder cancer, chronic lymphocytic leukemia, mantle cell lymphoma, and myeloma.

Share

Supporters

Advances in Targeted Therapeutics for Biliary Tract Cancer
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

BCMA Immunotherapy, Bispecific Platforms, and CD38 Antibodies in Myeloma: Optimizing Treatment & Enhancing Access
Supported by an educational grant from Sanofi Genzyme.

Redefining Precision Therapeutics in Hematologic Malignancies: Current Practice and Next Questions on Bispecific Antibodies
Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Next-Generation Care for Patients With Bladder Cancer
Supported by an educational grant from Merck Sharp & Dohme LLC.

Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL
Supported by an educational grant from Merck Sharp & Dohme LLC.

Boehringer Ingelheim Pharmaceuticals, Inc.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC

Merck Sharp & Dohme, LLC

Sanofi Genzyme